INDV · ISSUER CIK 1625297
Indivior Pharmaceuticals, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Indivior Pharmaceuticals, Inc. insiders reported $108K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Anderson Woodrow D (Chief Accounting Officer), with $108K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$108KInsider buying
$0.00Insider selling
+$108KNet open-market
Aug 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 202616:00 | Aug 27, 2026 | INDV | Chief Accounting Officer | P · Buy | $35.69 | +1,500 | 27,638 | +6% | +$54K | -14.7% | -1.2% |
| Aug 5, 202616:52 | Aug 5, 2026 | INDV | Chief Accounting Officer | P · Buy | $36.28 | +1,500 | 26,138 | +6% | +$54K | -13.3% | -2.8% |